Recent Stories

Lloyd’s makes history with deputy chair assignment

Chinese firms’ class action woes highlight D&O cover

FM Global overhauls executive leadership team

Beazley secures financial results turnaround

Ping An issues first digital yuan insurance policies in China

Insurtech unicorn bolttech acquires European firm i-surance

Trending This Week

Finding the right mix: AML for cryptocurrency payments

Visa continues acquisitive direction with purchase of Currencycloud

Payments Cards & Mobile Jobs of the Week July 26

Mastercard ban in India set to cause issues for domestic banks

Payments Cards & Mobile Jobs of the Week July 19

Digital lenders must adopt better payment services to succeed

Real-time payments now as popular as cash in Southeast Asia

UK and Nordics lead Open Banking in Europe

Business & Finance

Business Management

Insurance

Editorial Choice

Lloyd’s makes history with deputy chair assignment

1 day ago

Chinese firms’ class action woes highlight D&O cover

1 day ago

FM Global overhauls executive leadership team

2 days ago

Beazley secures financial results turnaround

2 days ago

Ping An issues first digital yuan insurance policies in China

2 days ago

Insurtech unicorn bolttech acquires European firm i-surance

2 days ago

Marsh McLennan posts “outstanding” Q2 performance

2 days ago

Aon releases latest global catastrophe report

3 days ago

Lloyd’s makes history with deputy chair assignment

Chinese firms’ class action woes highlight D&O cover

Finding the right mix: AML for cryptocurrency payments

Visa continues acquisitive direction with purchase of Currencycloud

Coca-Cola, Travelers, Philip Morris, Lockheed & more

spike 1 year ago

Take a look at some of the biggest movers in the premarket:

Coca-Cola (KO) – Coca-Cola reported quarterly earnings of 51 cents per share, 7 cents a share above estimates. Revenue also came in above Wall Street forecasts. The company said a shift in consumer habits due to the Covid-19 pandemic would materially impact results this quarter but it is hopeful for a second-half rebound.

Travelers (TRV) – The insurance company earned $2.62 per share for the first quarter, compared to the consensus estimate of $2.85 a share. Revenue was also short of estimates, hit by higher catastrophe losses. Travelers

… Read More

Oil moves mixed on easing lockdowns, looming storage shortage

spike 1 year ago

LONDON (Reuters) – Oil prices were mixed on Tuesday as optimism about the easing of coronavirus-related restrictions reassured markets, although traders remained cautious with storage capacities filling up fast and supply cuts not deep enough to counter falling demand.

FILE PHOTO: An oil pump jack pumps oil in a field near Calgary, Alberta, Canada on July 21, 2014. REUTERS/Todd Korol

Brent crude LCOc1 rose 41 cents, or 2%, to $20.40 a barrel at 1006 GMT, following a 6.8% slide on Monday.

U.S. West Texas Intermediate (WTI) crude CLc1 was down 78 cents, or 6%, at $12.00 a barrel. The contract

… Read More

Buy now pay later set to disrupt e-commerce payments in APAC

spike 4 months ago

Buy now pay later (BNPL) has emerged as a viable credit option for e-commerce purchases in Asia-Pacific (APAC) as several payment companies are now offering this service in the region.

An analysis of GlobalData’s e-commerce analytics reveals that the APAC e-commerce market is set to grow at a compound annual growth rate of 17.6% from $1.2 trillion in 2016 to $3.6 trillion in 2023.

“The COVID-19 pandemic has not only adversely affected businesses but also consumers’ disposable income. As a result, with rise in demand for consumer financing and growing e-commerce sales buy now and pay later service has emerged

… Read More

U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine

spike 1 year ago

BENGALURU/LONDON (Reuters) – The United States has secured almost a third of the first one billion doses planned for AstraZeneca’s experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.

While not proven to be effective against the coronavirus, vaccines are seen by world leaders as the only real way to restart their stalled economies, and even to get an edge over global competitors.

After President Donald Trump demanded a vaccine, the U.S. Department of Health and Human Services agreed to provide up to $1.2 billion to accelerate

… Read More